IQGAP3, of which the expression could be upregulated by BET inhibition, constrained RAS signaling and specifically prognosticated a subgroup of DLBCL patients whose tumors harbored enhanced PI3K activity. The gene discussed is IQGAP3; the disease is diffuse large B-cell lymphoma.